Target intelligence / Profile preview

SERPINB2-SERPINB10 readthrough

Molecular classification
Enzyme inhibitor (Serine protease inhibitor, clade B serpin family), Other (Intracellular serpin; some members have nuclear localization)
01

Overview

The referenced entity "SERPINB2-SERPINB10 readthrough" is not a well-validated or functionally characterized protein, but rather a predicted transcript overlapping two serpin family genes. The individual proteins, SERPINB2 (Plasminogen activator inhibitor 2, PAI-2) and SERPINB10 (Bomapin), are intracellular serine protease inhibitors in clade B of the serpin family. SERPINB2 plays roles in the regulation of cell senescence, inflammation, and protease activity, particularly affecting urokinase and tissue plasminogen activator. SERPINB10 regulates protease function during hematopoiesis and influences allergic airway inflammation. Both proteins are involved in immune system regulation, apoptosis, and have been implicated as biomarkers in various disease processes including cancer and inflammatory conditions.

Other names
SERPINB2Plasminogen activator inhibitor 2PAI-2SERPINB10Bomapin
02

Mechanism of action

For the individual proteins: - Protease inhibition: blocks serine protease activity (e.g., uPA, tPA for SERPINB2; trypsin, thrombin for SERPINB10). - Regulation of apoptosis (SERPINB10: affects TNF-induced apoptosis).

03

Biological functions

SERPINB2: Inhibition of urokinase and tissue plasminogen activator (uPA, tPA)SERPINB2: Regulation of senescence via stabilization of p21SERPINB2: Inflammatory response, protection from proteotoxic stressSERPINB2: Cell migration, apoptosisSERPINB10: Regulation of protease activities during hematopoiesis and apoptosis, especially TNF-induced apoptotic pathwaysSERPINB10: Modulation of allergic airway inflammation via periostin and CCL26
04

Disease associations

SERPINB2: Associated with senescence (biomarker)SERPINB2: Implicated in angioedemaSERPINB2: Role in inflammation, cell migration, and macrophage functionSERPINB10: Linked to tracheal calcification, myringitis bullosa hemorrhagica, risk of prostate cancerSERPINB10: Higher expression in asthmatic inflammatory states
05

Safety considerations

No clinical data exist for drugs targeting the SERPINB2-SERPINB10 readthrough.For SERPINB2/SERPINB10, overexpression is associated with inflammation and possible tissue damage, but no direct therapeutic safety concerns are well defined.
06

Biomarkers

SERPINB2: senescence biomarker (elevated levels in senescent cells)SERPINB2/SERPINB10: potential biomarker for inflammation (e.g., asthma, allergic responses)

Beyond the preview

Go deeper on SERPINB2-SERPINB10 readthrough.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SERPINB2-SERPINB10 readthrough.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call